Vident Investment Advisory’s Iovance Biotherapeutics IOVA Stock Holding History

Vident Investment Advisory’s Portfolio IOVA Stock Details IOVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-112,238	Closed	-$686K	–	1261
2023 Q1	$686K	Sell	112,238 -3,288	-3%	-$22.7K	0.02%	659
2022 Q4	$738K	Buy	115,526 +38,897	+51%	+$304K	0.03%	576
2022 Q3	$731K	Sell	76,629 -8,010	-9%	-$92.4K	0.02%	678
2022 Q2	$934K	Buy	84,639 +20,434	+32%	+$268K	0.03%	642
2022 Q1	$1.07M	Buy	64,205 +10,540	+20%	+$163K	0.03%	673
2021 Q4	$1.02M	Sell	53,665 -9,320	-15%	-$205K	0.03%	698
2021 Q3	$1.55M	Sell	62,985 -4,500	-7%	-$106K	0.05%	540
2021 Q2	$1.76M	Buy	67,485 +34,477	+104%	+$896K	0.05%	462
2021 Q1	$1.04M	Hold	33,008	–	–	0.04%	600
2020 Q4	$1.53M	Sell	33,008 -8,981	-21%	-$357K	0.06%	395
2020 Q3	$1.38M	Sell	41,989 -6,087	-13%	-$187K	0.07%	402
2020 Q2	$1.32M	Sell	48,076 -11,611	-19%	-$382K	0.07%	381
2020 Q1	$1.79M	Sell	59,687 -1,736	-3%	-$46K	0.12%	201
2019 Q4	$1.7M	Sell	61,423 -11,494	-16%	-$261K	0.11%	298
2019 Q3	$1.33M	Sell	72,917 -2,083	-3%	-$46.1K	0.12%	131
2019 Q2	$1.84M	Sell	75,000 -81,495	-52%	-$1.23M	0.15%	96
2019 Q1	$1.49M	Sell	156,495 -5,162	-3%	-$50.1K	0.08%	349
2018 Q4	$1.43M	Sell	161,657 -17,822	-10%	-$172K	0.08%	333
2018 Q3	$2.02M	Sell	179,479 -12,940	-7%	-$184K	0.08%	327
2018 Q2	$2.46M	Sell	192,419 -17,911	-9%	-$262K	0.1%	280
2018 Q1	$3.1M	Buy	210,330 +57,136	+37%	+$865K	0.13%	229
2017 Q4	$1.23M	Sell	153,194 -32,434	-17%	-$260K	0.06%	347
2017 Q3	$1.44M	Hold	185,628	–	–	0.08%	320
2017 Q2	$1.36M	Buy	185,628 +60,092	+48%	+$382K	0.11%	287
2017 Q1	$935K	Buy	125,536 +20,920	+20%	+$153K	0.09%	310
2016 Q4	$727K	Buy	104,616 +17,220	+20%	+$118K	0.09%	310
2016 Q3	$719K	Buy	87,396 +1,689	+2%	+$14.3K	0.1%	313
2016 Q2	$694K	Sell	85,707 -91,013	-52%	-$572K	0.1%	319
2016 Q1	$898	Buy	176,720 +84,567	+92%	+$463K	0.06%	356
2015 Q4	$711K	Buy	+92,153	New	+$639K	0.09%	346